A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

(Reuters) -Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of recommending that ...

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.